Dongwha Pharm.Co.,Ltd

₩5,150As of Sun 8 Nov 2026, 12:00 UTC
KRX:000020Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (2.51%)
Div yield 1.26%
ROE 3.57%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.36
PE TTM 7.897
TSR TTM (16.82%)
Mkt cap ₩142.7B
ROIC 3.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩5,532
7.42%
(54.55%)
Hold 3|11|11|7|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
105.84
103.52
104.81
104.47
38.28%
21.55%
13.79%
6.12%
Revenue₩B
10.11
10.38
10.85
11.11
11.34%
8.54%
7.57%
10.34%
Peers (US$105.2M)
Cap (US$)
PE
106.9M
26.43x
106.3M
3.616x
Capital
TTM
5Y
10Y
Leveragex
0.398
(0.416)
(0.314)
EBIT/Intx
2.766
0.545
0.551
Own earn%
(65.22)
24.63
28.89
Sh yield%
48.90
37.67
33.79
Owners
Insiders/Inst%
7.58
66.24
Short interest%
2.02
SBC / revenue%
2.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
18–23
$1 testx
0.0
Incr. ROIC%
9